Special Issue "Emerging Classes of Biomarkers for Molecular Diagnostics"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (28 February 2015).
Prof. Dr. Camile S. Farah
Head, Oral Oncology Research Program, UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women’s Hospital, Herston, Qld 4029, Australia
Website | E-Mail
Interests: biomarkers of oral cancer and oral epithelial dysplasia; oral oncology; personalized medicine; next generation sequencing; immunohistochemistry; molecular diagnostics; molecular tumour stratification; microRNA; optical biopsy; molecular imaging
There has been an explosion of biomarker research in the last five years, and much interest in diagnostic, prognostic and predictive products utilised in the ever expanding field of personalized medicine. Biomarker research has become at once more sophisticated yet more profuse, and we currently have a plethora of biomarkers for a diverse range of diseases from heart failure to oral cancer. As we explore these biomarkers further, we must endeavour to learn about the underlying mechanisms of disease processes, as we move along the path to discovery of novel drugs and therapies that will increase our ability to offer personalized patient care into the future. With the migration of advanced high throughput technologies, such as Next Generation Sequencing from the research arena into clinical practice, biomarker research and discovery is poised to explode once again. Translation of novel biomarkers into clinical practice and diagnostic laboratories is coupled with regulatory and administrative requirements that must be met, while collaboration between research institutions, industry and the private sector drive further advancements in the field of biomarker discovery and application. This Special Issue explores the ever expanding field of emerging biomarkers for molecular diagnostics and their application in the clinical setting, and their potential utility in personalized patient care.
Prof. Dr. Camile S Farah
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cancer biomarkers
- cancer stem cells
- clinical trials
- circulating biomarkers
- companion diagnostics
- copy number variation
- diagnostic imaging
- digital PCR
- emerging biomarkers
- genome-wide association studies
- genomic database
- lab-on-a-chip diagnostics
- liquid biopsy
- massively parallel sequencing
- molecular diagnostics
- molecular pathology
- molecular imaging
- nanofluidics next-generation sequencing
- deep sequencing
- non-coding RNAs
- personalized medicine
- point-of-care diagnostics
- precision medicine
- predictive diagnostics
- prognostic diagnostics
- single nucleotide polymorphism
- single cell sequencing
- targeted therapy
- translational medicine